[1]
Verma, M., Gupta, S., Bhagat, B.R., Mahajan, A. and Kaur, B. 2018. Comparison of intravenous hydralazine and intravenous labetalol in the management of severe hypertensive disorders of pregnancy: a tertiary care centre study. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 7, 6 (May 2018), 2251–2256. DOI:https://doi.org/10.18203/2320-1770.ijrcog20182330.